Citation: Gl. Zornberg, IDENTIFYING CRITICAL PERIODS OF NEURODEVELOPMENTAL RISK - THE TURNING-POINT IN SCHIZOPHRENIA RESEARCH, Harvard review of psychiatry, 6(3), 1998, pp. 171-174
Authors:
BUKA SL
GOLDSTEIN JM
SEIDMAN LJ
ZORNBERG GL
DENNY LR
TSUANG MT
Citation: Sl. Buka et al., CHRONIC FETAL HYPOXIA AND OTHER OBSTETRIC RISK-FACTORS FOR PSYCHOTIC ILLNESS - A REPLICATION STUDY, Schizophrenia research, 29(1-2), 1998, pp. 14-14
Authors:
ROBERTS LW
MCCARTY T
LYKETSOS C
HARDEE JT
JACOBSON J
WALKER R
HOUGH P
GRAMELSPACHER G
STIDLEY CA
ARAMBULA M
HEEBINK DM
ZORNBERG GL
SIEGLER M
Citation: Lw. Roberts et al., WHAT AND HOW PSYCHIATRY RESIDENTS AT 10 TRAINING-PROGRAMS WISH TO LEARN ABOUT ETHICS, Academic psychiatry, 20(3), 1996, pp. 131-143
Authors:
BODKIN JA
COHEN BM
SALOMON MS
CANNON SE
ZORNBERG GL
COLE JO
Citation: Ja. Bodkin et al., TREATMENT OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER BY SELEGILINE AUGMENTATION OF ANTIPSYCHOTIC MEDICATION - A PILOT-STUDY EXAMINING THE ROLE OF DOPAMINE, The Journal of nervous and mental disease, 184(5), 1996, pp. 295-301
Citation: Gl. Zornberg et Hg. Pope, TREATMENT OF DEPRESSION IN BIPOLAR DISORDER - NEW DIRECTIONS FOR RESEARCH, Journal of clinical psychopharmacology, 13(6), 1993, pp. 397-408
Citation: Gl. Zornberg et Jd. Hegarty, ADVERSE INTERACTION BETWEEN PROPOXYPHENE AND PHENELZINE, The American journal of psychiatry, 150(8), 1993, pp. 1270-1271